265 related articles for article (PubMed ID: 30546950)
1. B cells in esophago-gastric adenocarcinoma are highly differentiated, organize in tertiary lymphoid structures and produce tumor-specific antibodies.
Schlößer HA; Thelen M; Lechner A; Wennhold K; Garcia-Marquez MA; Rothschild SI; Staib E; Zander T; Beutner D; Gathof B; Gilles R; Cukuroglu E; Göke J; Shimabukuro-Vornhagen A; Drebber U; Quaas A; Bruns CJ; Hölscher AH; Von Bergwelt-Baildon MS
Oncoimmunology; 2019; 8(1):e1512458. PubMed ID: 30546950
[TBL] [Abstract][Full Text] [Related]
2. CD86
Wennhold K; Thelen M; Lehmann J; Schran S; Preugszat E; Garcia-Marquez M; Lechner A; Shimabukuro-Vornhagen A; Ercanoglu MS; Klein F; Thangarajah F; Eidt S; Löser H; Bruns C; Quaas A; von Bergwelt-Baildon M; Schlößer HA
Cancer Immunol Res; 2021 Sep; 9(9):1098-1108. PubMed ID: 34155067
[TBL] [Abstract][Full Text] [Related]
3. Immunological potential of tertiary lymphoid structures surrounding the primary tumor in gastric cancer.
Yamakoshi Y; Tanaka H; Sakimura C; Deguchi S; Mori T; Tamura T; Toyokawa T; Muguruma K; Hirakawa K; Ohira M
Int J Oncol; 2020 Jul; 57(1):171-182. PubMed ID: 32319601
[TBL] [Abstract][Full Text] [Related]
4. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
[TBL] [Abstract][Full Text] [Related]
5. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
N J; J T; Sl N; Gt B
Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Infiltrating Plasma Cells Are Associated with Tertiary Lymphoid Structures, Cytolytic T-Cell Responses, and Superior Prognosis in Ovarian Cancer.
Kroeger DR; Milne K; Nelson BH
Clin Cancer Res; 2016 Jun; 22(12):3005-15. PubMed ID: 26763251
[TBL] [Abstract][Full Text] [Related]
7. Immune responses against shared antigens are common in esophago-gastric cancer and can be enhanced using CD40-activated B cells.
Thelen M; Keller D; Lehmann J; Wennhold K; Weitz H; Bauer E; Gathof B; Brüggemann M; Kotrova M; Quaas A; Mallmann C; Chon SH; Hillmer AM; Bruns C; von Bergwelt-Baildon M; Garcia-Marquez MA; Schlößer HA
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600602
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.
Tanaka T; Masuda A; Inoue J; Hamada T; Ikegawa T; Toyama H; Sofue K; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Ueda Y; Fukumoto T; Kodama Y
J Gastroenterol; 2023 Mar; 58(3):277-291. PubMed ID: 36705749
[TBL] [Abstract][Full Text] [Related]
9. Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?
Fridman WH; Sibéril S; Pupier G; Soussan S; Sautès-Fridman C
Semin Immunol; 2023 Jan; 65():101703. PubMed ID: 36481358
[TBL] [Abstract][Full Text] [Related]
10. Investigating Tumor-Associated Tertiary Lymphoid Structures in Murine Lung Adenocarcinoma.
Connolly KA; Nader M; Joshi N
Methods Mol Biol; 2018; 1845():259-273. PubMed ID: 30141018
[TBL] [Abstract][Full Text] [Related]
11. The Tumor Immune Landscape and Architecture of Tertiary Lymphoid Structures in Urothelial Cancer.
van Dijk N; Gil-Jimenez A; Silina K; van Montfoort ML; Einerhand S; Jonkman L; Voskuilen CS; Peters D; Sanders J; Lubeck Y; Broeks A; Hooijberg E; Vis DJ; van den Broek M; Wessels LFA; van Rhijn BWG; van der Heijden MS
Front Immunol; 2021; 12():793964. PubMed ID: 34987518
[TBL] [Abstract][Full Text] [Related]
12. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
13. Characterization of tumor-associated T-lymphocyte subsets and immune checkpoint molecules in head and neck squamous cell carcinoma.
Lechner A; Schlößer H; Rothschild SI; Thelen M; Reuter S; Zentis P; Shimabukuro-Vornhagen A; Theurich S; Wennhold K; Garcia-Marquez M; Tharun L; Quaas A; Schauss A; Isensee J; Hucho T; Huebbers C; von Bergwelt-Baildon M; Beutner D
Oncotarget; 2017 Jul; 8(27):44418-44433. PubMed ID: 28574843
[TBL] [Abstract][Full Text] [Related]
14. Tertiary Lymphoid Structure-B Cells Narrow Regulatory T Cells Impact in Lung Cancer Patients.
Germain C; Devi-Marulkar P; Knockaert S; Biton J; Kaplon H; Letaïef L; Goc J; Seguin-Givelet A; Gossot D; Girard N; Validire P; Lefèvre M; Damotte D; Alifano M; Lemoine FM; Steele KE; Teillaud JL; Hammond SA; Dieu-Nosjean MC
Front Immunol; 2021; 12():626776. PubMed ID: 33763071
[TBL] [Abstract][Full Text] [Related]
15. Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.
Germain C; Gnjatic S; Dieu-Nosjean MC
Front Immunol; 2015; 6():67. PubMed ID: 25755654
[TBL] [Abstract][Full Text] [Related]
16. Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Germain C; Gnjatic S; Tamzalit F; Knockaert S; Remark R; Goc J; Lepelley A; Becht E; Katsahian S; Bizouard G; Validire P; Damotte D; Alifano M; Magdeleinat P; Cremer I; Teillaud JL; Fridman WH; Sautès-Fridman C; Dieu-Nosjean MC
Am J Respir Crit Care Med; 2014 Apr; 189(7):832-44. PubMed ID: 24484236
[TBL] [Abstract][Full Text] [Related]
17. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
Pagliarulo F; Cheng PF; Brugger L; van Dijk N; van den Heijden M; Levesque MP; Silina K; van den Broek M
Front Immunol; 2021; 12():793992. PubMed ID: 35145509
[TBL] [Abstract][Full Text] [Related]
18. Identification of Tertiary Lymphoid Structure-Associated Follicular Helper T Cells in Human Tumors and Tissues.
Couillault C; Germain C; Dubois B; Kaplon H
Methods Mol Biol; 2018; 1845():205-222. PubMed ID: 30141015
[TBL] [Abstract][Full Text] [Related]
19. Integrative prognostic analysis of tumor-infiltrating lymphocytes, CD8, CD20, programmed cell death-ligand 1, and tertiary lymphoid structures in patients with early-stage triple-negative breast cancer who did not receive adjuvant chemotherapy.
Yazaki S; Shimoi T; Yoshida M; Sumiyoshi-Okuma H; Arakaki M; Saito A; Kita S; Yamamoto K; Kojima Y; Nishikawa T; Tanioka M; Sudo K; Noguchi E; Murata T; Shiino S; Takayama S; Suto A; Ohe Y; Fujiwara Y; Yonemori K
Breast Cancer Res Treat; 2023 Jan; 197(2):287-297. PubMed ID: 36385236
[TBL] [Abstract][Full Text] [Related]
20. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
